LEADS BIOLABS’ OPAMTISTOMIG (PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED FDA FAST TRACK DESIGNATION FOR FIRST-LINE ADVANCED OR METASTATIC BILIARY TRACT CANCER

Reuters · 2d ago

Please log in to view news